- Medical School - Baylor College of Medicine

Affan Zafar, M.D.
- Urology
- Bladder Cancer
- Prostate Cancer
New Patient Appointment Accepting Virtual Visits or 214-645-8765
Biography
Affan Zafar, M.D., is an Assistant Professor in the Department of Urology at UT Southwestern Medical Center. He specializes in genitourinary cancers including prostate, kidney, bladder, and testicular cancer.
Dr. Zafar earned his medical degree at Baylor College of Medicine. He completed a residency in urologic surgery at Washington University’s Barnes-Jewish Hospital and received advanced fellowship training in urologic oncology at Harvard Medical School. He joined the UT Southwestern faculty in 2023.
Dr. Zafar is a member of the American Urological Association and the Society of Urologic Oncology.
He has delivered presentations at national meetings and published peer-reviewed academic articles on bladder cancer and bladder preservation treatments.
Personal Note
When he’s not at work, Dr. Zafar enjoys spending time with his wife and two children, traveling, hiking, and reading.
Education & Training
Professional Associations & Affiliations
- American Urological Association
- Society of Urologic Oncology
Books & Publications
-
Books
-
Management of infertility in Klinefelter Syndrome in Male Infertility: A Clinical Approach
Ramasamy R, Zafar A (2017), New York, Springer
-
Management of infertility in Klinefelter Syndrome in Male Infertility: A Clinical Approach
-
Publications
-
Surgical Outcomes of Radical Nephrectomy and Inferior Vena Cava Thrombectomy Following Preoperative Systemic Immunotherapy: A Propensity Score Analysis.
Khene ZE, Bhanvadia R, Tachibana I, Issa W, Graber W, Trevino I, Woldu SL, Gaston K, Zafar A, Hammers H, Cole S, Zhang T, Bensalah K, Lotan Y, Margulis V, Clinical genitourinary cancer 2025 Jan 23 2 102307 -
Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis.
Hinojosa-Gonzalez DE, Zafar A, Saffati G, Kronstedt S, Zlatev DV, Khera M, Prostate cancer and prostatic diseases 2024 Jan -
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.
Yim K, Melnick K, Mott SL, Carvalho FLF, Zafar A, Clinton TN, Mossanen M, Steele GS, Hirsch M, Rizzo N, Wu CL, Mouw KW, Wszolek M, Salari K, Feldman A, Kibel AS, O'Donnell MA, Preston MA, Urologic oncology 2023 Sep -
Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer.
Weinberg MS, Zafar A, Magdamo C, Chung SY, Chou WH, Nayan M, Deodhar M, Frendl DM, Feldman AS, Faustman DL, Arnold SE, Vakulenko-Lagun B, Das S, JAMA network open 2023 May 6 5 e2314336 -
Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study.
Stavrou E, Qiu J, Zafar A, Tramontano AC, Isakoff S, Winer E, Schrag D, Manz C, JCO oncology practice 2022 Sep 18 9 e1447-e1453 -
Dual-frequency setting for urinary stone fragmentation during shock wave lithotripsy: an in vitro study.
Han CS, Vetter JM, Endicott R, Chevinsky M, Zafar A, Venkatesh R, Urolithiasis 2020 Aug 48 4 369-375
-
Surgical Outcomes of Radical Nephrectomy and Inferior Vena Cava Thrombectomy Following Preoperative Systemic Immunotherapy: A Propensity Score Analysis.
Research
- Improving surveillance for prostate and bladder cancer
- Improving bladder preservation treatments for bladder cancer
Clinical Focus
- Bladder Cancer
- Prostate Cancer
- Kidney Cancer
- Testicular Cancer
- Robotic Surgery
Results: 1 Locations
Urology
at UT Southwestern Medical Center at Richardson/Plano 3030 Waterview Parkway, 1st FloorRichardson, Texas 75080 972-669-7007 Directions to Urology
New Patient Appointment Accepting Virtual Visits or 214-645-8765